CS
INSY

Candriam SCA’s Insys Therapeutics, Inc. INSY Stock Holding History

Candriam SCA’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,500
Closed -$85K – 855
2019
Q1 		$85K Buy
+18,500
New +$87.6K ﹤0.01% 785

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Candriam SCA's INSY Position: Q2 2019 in Review

Candriam SCA sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 18,500 shares — an estimated $85K sold.

Candriam SCA first reported a position in INSY in Q1 2019 and held it in 1 quarter. The position peaked at $85K in Q1 2019. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Candriam SCA reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Candriam SCA sold 18,500 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $85K.
  • Candriam SCA first reported a position in Insys Therapeutics, Inc. in Q1 2019 and held it in 1 quarter.
  • Candriam SCA's Insys Therapeutics, Inc. position peaked at $85K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.